Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04764942
Status:
RECRUITING
Last Update Posted:
2024-01-17
First Post:
2021-02-17
Brief Title:
Selinexor Pomalidomide and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma The SCOPE Trial
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-04
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-17
First Submit QC Date:
February 17 2021
Study First Post Date:
2021-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-15
Last Update Post Date:
2024-01-17
Last Update Post Date Type:
ACTUAL